Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis
Allergy · 2023-06 · 78 (6) · 1425-1440
DOI: 10.1111/all.15729 ↗At a glance
Übersichtsarbeit in Allergy, published online on 2023-04-01. Written by Ming Wang and 4 co-authors. Institution: Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China. Major MEDLINE topics: Rhinitis, Allergic, Mesenchymal Stem Cells. Cited 34 times so far (Crossref); 198 references.
Abstract (original language)
Allergic rhinitis is a highly prevalent chronic inflammatory disorder of the nasal mucosa that poses a significant burden on patients' health and quality of life. Current therapies for allergic rhinitis are unable to reinstate immune homeostasis or are restricted by specific allergens. Potential therapeutic strategies for allergic rhinitis are urgently needed. Mesenchymal stem cells (MSCs) are immune‐privileged, have strong immunomodulatory effects, and can be easily isolated from various sources. Thus, MSC‐based therapies demonstrate potential for treating inflammatory diseases. Recently, numerous studies have investigated the therapeutic effects of MSCs in animal models of allergic rhinitis. Here, we review the immunomodulatory effects and mechanisms of MSCs on allergic airway inflammation, especially allergic rhinitis, highlight the recent research regarding MSCs in the modulation of immune cells, and discuss the clinical potential of MSC‐based therapy for allergic rhinitis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China.
- Beijing Key Laboratory of Nasal Diseases, Beijing Laboratory of Allergic Diseases, Beijing Institute of Otolaryngology, Beijing, 100005, China.
- Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
- Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China.
ORCID profiles: Ming Wang, Ning Zhao, Chengshuo Wang, Zi-Bing Jin, Luo Zhang
Cite
APA
Wang, M., Zhao, N., Wang, C., Jin, Z. B., & Zhang, L. (2023). Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis. Allergy, 78(6), 1425-1440. https://doi.org/10.1111/all.15729
Vancouver
Wang M, Zhao N, Wang C, Jin ZB, Zhang L. Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis. Allergy. 2023;78(6):1425-1440. doi:10.1111/all.15729
BibTeX
@article{Wang2023,
author = {Wang, Ming and Zhao, Ning and Wang, Chengshuo and Jin, Zi-Bing and Zhang, Luo},
title = {Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis},
journal = {Allergy},
year = {2023},
volume = {78},
number = {6},
pages = {1425--1440},
doi = {10.1111/all.15729}
}
EUVIMED